Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001200106 | SCV001370978 | likely pathogenic | not provided | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847187 | SCV002105859 | uncertain significance | Hereditary spastic paraplegia | 2016-12-12 | criteria provided, single submitter | clinical testing | |
PROSPAX |
RCV001542601 | SCV005061876 | likely pathogenic | Hereditary spastic paraplegia 7 | 2022-01-01 | criteria provided, single submitter | research | |
Genomics England Pilot Project, |
RCV001542601 | SCV001760392 | pathogenic | Hereditary spastic paraplegia 7 | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001200106 | SCV001959575 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001200106 | SCV001968773 | uncertain significance | not provided | no assertion criteria provided | clinical testing |